recurrent endometrial endometrioid adenocarcinoma
Showing 1 - 7 of 7
Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid
Not yet recruiting
- Recurrent Endometrial Carcinoma
- +8 more
- BET Bromodomain Inhibitor ZEN-3694
- +7 more
- (no location specified)
Jul 15, 2023
Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma
Active, not recruiting
- Recurrent Endometrial Endometrioid Adenocarcinoma
- +4 more
-
Anchorage, Alaska
- +584 more
Jan 28, 2023
Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma Trial in
Recruiting
- Recurrent Endometrial Adenocarcinoma
- +8 more
- Ipilimumab
- Nivolumab
-
Iowa City, Iowa
- +9 more
Jan 27, 2023
Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in
Recruiting
- Recurrent Endometrial Carcinoma
- +12 more
- Everolimus
- +2 more
-
Houston, Texas
- +1 more
Sep 22, 2022
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic
Not yet recruiting
- FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
- +4 more
- Computed Tomography
- +3 more
- (no location specified)
Sep 13, 2022
Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma Trial in
Recruiting
- Endometrial Clear Cell Adenocarcinoma
- +17 more
- Carboplatin
- +5 more
-
Birmingham, Alabama
- +376 more
Aug 24, 2022
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Mucinous Adenocarcinoma, Endometrial
Active, not recruiting
- Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
- +7 more
- 3-Dimensional Conformal Radiation Therapy
- +3 more
-
Auburn, California
- +440 more
Sep 28, 2021